List of high-quality authors
Kelun Pharmaceutical: The company obtained drug registration approval].
Kelun Pharmaceutical announced that the company's -3 triglycerides (2%), medium long-chain fat emulsion amino acids (16) and glucose (16%) injection have been approved for drug registration.
Changlian shares: net profit in 2023 is 15.3 billion yuan, down 552%】
Changlian Co., Ltd. announced the announcement of the 2023 annual performance express report, and the total operating income in the reporting period was 163.2 billion yuan, down 034%；Net profit attributable to shareholders of listed companies15.3 billion yuan, down 552%。
ST Information and Communications: Director and President Cao Xing resigned
ST announced that the board of directors received a written resignation application from Ms. Cao Xing, director and president. Due to personal reasons, Ms. Cao Xing applied to the Board of Directors of the Company to resign as a director of the ninth session of the Board of Directors, a member of the Strategy and Investment Committee of the Board of Directors and the President of the Company.
Wanbangde: The subsidiary obtained the notice of approval of the marketing application of tenofovir alafenol fumarate chemical API].
Wanbond announced that its wholly-owned subsidiary, Wanbond Pharmaceutical Group, recently received the "Notice of Approval of the Marketing Application for Chemical APIs" of tenofovir alafenamide fumarate approved and issued by the State Drug Administration.